Rankings
▼
Calendar
LGVN Q1 2022 Earnings — Longeveron Inc. Revenue & Financial Results | Market Cap Arena
LGVN
Longeveron Inc.
$20M
Q1 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$370,000
-1.6% YoY
Gross Profit
$165,000
44.6% margin
Operating Income
-$3M
-917.3% margin
Net Income
-$4M
-948.6% margin
EPS (Diluted)
$-1.70
QoQ Revenue Growth
+77.0%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$491,000
Balance Sheet
Total Assets
$39M
Total Liabilities
$5M
Stockholders' Equity
$34M
Cash & Equivalents
$22M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$370,000
$376,000
-1.6%
Gross Profit
$165,000
$149,000
+10.7%
Operating Income
-$3M
-$3M
+1.9%
Net Income
-$4M
-$3M
-12.8%
← FY 2022
All Quarters
Q2 2022 →